Aging Overview

External factors

External factors: Sargahydroquinoic acid
Aging type: Prevent
Aging characteristic:
Category: Chemical compounds
Phenotype: Aging
Experimental category: L
Tissue type: --
Cell name: HUVEC
PMID: 34022274
Experiment: Western blot//SA-β-gal activity assay//Cell viability assay
Description: Short-term exposure to low doseH2O2 elevated protein expression of three senescence biomarkers, p53, p21, and p16, whose levels were suppressed by SHQA in a dose-dependentmanner.Whereas,SHQA suppressed the SA-β-Gal positive cell abundance at all three tested concentrations. The SA-β-Gal positive cell percentages were around 24%, 18% and 12% when pretreated with 0.5, 1.0, or 2.0 μM SHQA, respectively. Culturing and passaging HUVECs in growth medium supplemented with 2.0 μM SHQA remarkably delayed the cellular growth arrest. When cultured in normal medium supplemented with DMSO, the growth of HUVECs was arrested at 23.9 PDL (population doubling), whereas the supplementation of SHQA extended the cell growth to 26.3 PDL.The SA-β-Gal positive cells were significantly lower in cells supplemented with SHQA at PDL24 (24%), compared to cells cultured with DMSO at PDL23 (51%). SHQA treatment also reduced the protein expression levels of p53, p21, and p16 in senescent cells.


Regulatory relationship

Target gene: AKT//MTOR
R-EF-Target gene: Downregulation
Official symbol(s): AKT//MTOR
Target gene experiment: Western blot
Target gene description: However, the H2O2-induced hyperphosphorylation of Akt and mTOR was suppressed by SHQA at 1.0 μM and 2.0 μM.SHQA inhibited the phosphoryla tion of Akt, mTOR at all three concentrations tested.

Regulatory pathway: Akt-mTOR
R-EF-Pathway: Downregulation
Official symbol(s): AKT1-MTOR
Pathway experiment: Western blot
Pathway description: However, the H2O2-induced hyperphosphorylation of Akt and mTOR was suppressed by SHQA at 1.0 μM and 2.0 μM.SHQA inhibited the phosphoryla tion of Akt, mTOR at all three concentrations tested.


Aging network

Annotation:

The green line represents Upregulation.

The purple line represents Downregulation.

The orange line represents Activation.

The yellow line represents Inhibition.

The gray line represents Unclear.



Pathway view